← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$299K

Shares

14,860

Price

$20

Filed

Sep 3

Insider

Name

Kaye Edward M. MD

Title

CIK

0001522780

Roles

Director

Transaction Details

Transaction Date

2025-09-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

137,581

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.

Filing Info

Accession No.

0001415889-25-023590

Form Type

4

Issuer CIK

0001623526

Kaye Edward M. MD's History

Date Ticker Type Value
2026-04-15 CYTK A $12K
2025-12-08 STOK $120K
2025-12-08 STOK $269K
2025-12-08 STOK $44K
2025-12-05 STOK $199K
2025-12-05 STOK $52K
2025-12-05 STOK $16K
2025-12-04 STOK $161K
2025-12-04 STOK $39K
2025-12-03 STOK $13K

Other Insiders at STOK (90d)

Insider Bought Sold Last
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20